Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | Advancements in Parkinson’s disease treatment

Per Odin • 27 May 2020
EAN 2020
Movement Disorders Parkinson's Disease

Per Odin, MD, PhD, Lund University, Lund, Sweden, updates us on developments in Parkinson’s disease therapies. Prof. Odin briefly discusses developments in drug delivery, improvement of stereotactic treatments and management of non-motor symptoms. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Per Odin

1:14
Continuous dopaminergic stimulation: Advanced treatments in Parkinson’s disease
Per Odin • 17 Sep 2022
1:39
Quality of life in patients with late-stage Parkinson’s disease
Per Odin • 17 Sep 2022
0:56
Barriers to effective symptom management in Parkinson’s disease
Per Odin • 17 Sep 2022
0:53
Tools to monitor motor fluctuations in Parkinson's disease
Per Odin • 17 Oct 2022

Related Videos

5:26
Pridopidine shows benefit for patients with early HD not on antidopaminergic therapies
Michael Hayden • 16 Apr 2024
2:51
Overlap in etiology between different FND subtypes
Mark Hallett • 15 Apr 2024
1:58
Ambroxol & other targeted therapies in Parkinson's
K Ray Chaudhuri • 21 Mar 2024
3:00
The use of precision medicine in Parkinson’s disease
K Ray Chaudhuri • 21 Mar 2024
The content of VJNeurology is intended for healthcare professionals